Investigative Site

Madrid 28050

1 studies enrolling now · 7 studies all time

What they study most

CLE, Covid19, Cutaneous Lupus Erythematosus (CLE), Diabetes, Diabetic Nephropathy, Hypertension, Pancreatic Cancer, Rheumatoid Arthritis, SLE, SLE (Systemic Lupus), Systemic Lupus Erythematosus

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — Recruiting now
• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19 — Completed
• A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients — Completed
• GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy — Completed
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria — Completed
• Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension — Completed